Li Y - Search Results

1

CD161⁺CD127⁺CD8⁺ T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus.

Qu J, Li Y, Wu B, Shen Q, Chen L, Sun W, Wang B, Ying L, Wu L, Zhou H, Zhou J, Zhou J. Qu J, et al. Among authors: li y. Oncoimmunology. 2024 Jun 27;13(1):2371575. doi: 10.1080/2162402X.2024.2371575. eCollection 2024. Oncoimmunology. 2024. PMID: 38952673 Free PMC article.

2

Efficacy and surgical safety of sequential surgical resection after pembrolizumab plus chemotherapy for initial unresectable stage IIIB non-small cell lung cancer.

Zheng J, Li Y, Jin C, Ruan K, Sun K, Chen H, Wang M, Zhang S, Zhou J, Zhou J. Zheng J, et al. Among authors: li y. Lung Cancer. 2023 Oct;184:107326. doi: 10.1016/j.lungcan.2023.107326. Epub 2023 Aug 11. Lung Cancer. 2023. PMID: 37579576 Free article.

3

Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity.

Yuan T, Zeng C, Liu J, Zhao C, Ge F, Li Y, Qian M, Du J, Wang W, Li Y, Liu Y, Dai X, Zhou J, Chen X, Ma S, Zhu H, He Q, Yang B. Yuan T, et al. Among authors: li y. Signal Transduct Target Ther. 2024 Jan 5;9(1):11. doi: 10.1038/s41392-023-01706-y. Signal Transduct Target Ther. 2024. PMID: 38177135 Free PMC article.

4

Identifying risk factors and biomarkers for severe CIP in lung cancer patients- a retrospective case series study.

Wu G, Qu J, Zheng J, Wu B, Wang T, Gan Y, Jiang N, Li Y, Liu J, Zhou J, Zhou J. Wu G, et al. Among authors: li y. Immunotherapy. 2024;16(18-19):1131-1140. doi: 10.1080/1750743X.2024.2429369. Epub 2024 Nov 26. Immunotherapy. 2024. PMID: 39589860

5

Ivacaftor, a CFTR potentiator, synergizes with osimertinib against acquired resistance to osimertinib in NSCLC by regulating CFTR-PTEN-AKT axis.

Li YK, Ge FJ, Liu XN, Zeng CM, Qian MJ, Li YH, Zheng MM, Qu JJ, Fang LJ, Lu JJ, Yang B, He QJ, Zhou JY, Zhu H. Li YK, et al. Acta Pharmacol Sin. 2024 Dec 3. doi: 10.1038/s41401-024-01427-0. Online ahead of print. Acta Pharmacol Sin. 2024. PMID: 39627385

6

AKR1C1 connects autophagy and oxidative stress by interacting with SQSTM1 in a catalytic-independent manner.

Chang LL, Li YK, Zhao CX, Zeng CM, Ge FJ, Du JM, Zhang WZ, Lu PH, He QJ, Zhu H, Yang B. Chang LL, et al. Acta Pharmacol Sin. 2022 Mar;43(3):703-711. doi: 10.1038/s41401-021-00673-w. Epub 2021 May 20. Acta Pharmacol Sin. 2022. PMID: 34017066 Free PMC article.

7

Deubiquitinating enzymes: Promising targets for drug resistance.

Ge F, Li Y, Yuan T, Wu Y, He Q, Yang B, Zhu H. Ge F, et al. Among authors: li y. Drug Discov Today. 2022 Sep;27(9):2603-2613. doi: 10.1016/j.drudis.2022.06.009. Epub 2022 Jun 24. Drug Discov Today. 2022. PMID: 35760282 Review.

8

Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets.

Zeng C, Zhao C, Ge F, Li Y, Cao J, Ying M, Lu J, He Q, Yang B, Dai X, Zhu H. Zeng C, et al. Among authors: li y. Front Pharmacol. 2020 Aug 26;11:1311. doi: 10.3389/fphar.2020.01311. eCollection 2020. Front Pharmacol. 2020. PMID: 32982735 Free PMC article. Review.

9

Determination of 115 Pesticide Residues in Textiles by Liquid Chromatography-Tandem Mass Spectrometry.

Li Y, Ye X, Luo X, Zhu W, Tang Z, Niu Z. Li Y, et al. Rapid Commun Mass Spectrom. 2025 May 15;39(9):e9992. doi: 10.1002/rcm.9992. Rapid Commun Mass Spectrom. 2025. PMID: 39865448

10

Meta-analysis of the ability of mutational profiles on the cancer genome atlas to predict prognosis in endometrial carcinoma.

Li YX, Fan Y, Cao SY, Zhang YF, Li JK. Li YX, et al. Int J Gynaecol Obstet. 2025 Jan 25. doi: 10.1002/ijgo.16157. Online ahead of print. Int J Gynaecol Obstet. 2025. PMID: 39865302 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241,103 results

Search Page

Filters